Ciaparrone M, Yamamoto H, Yao Y, Sgambato A, Cattoretti G, Tomita N, Monden T, Rotterdam H, Weinstein I B
Centro di Ricerche Oncologicalhe Giovanni XXXIII Università Cattolica del Sacro Cuore, Rome, Italy.
Cancer Res. 1998 Jan 1;58(1):114-22.
The cyclin-dependent kinase inhibitor p27Kip1 can inhibit the G1 to S transition of the cell cycle and is a putative tumor suppressor. However, our laboratory found that a variety of human cancer cell lines express relatively high levels of this protein and that this is often associated with increased expression of cyclin D1 or cyclin E. Therefore, in the present study we analyzed by immunohistochemistry the expression of p27Kip1 in a series of human tissue samples representing various stages of colon carcinogenesis, using 20 samples of normal colon mucosa, 20 hyperplastic polyps, 19 samples of adenomatous polyps, and 40 samples of various types of colorectal carcinomas. Parallel immunostaining was done for cyclin D1 and also for Ki67 to evaluate cell proliferation. An additional 17 human colon carcinoma samples, together with paired adjacent normal mucosa samples, were analyzed for levels of expression of the p27Kip1 protein by Western blot analysis, and 7 of these pairs of samples were examined by Northern blot analysis for levels of p27Kip1 mRNA. We did not find a positive or negative correlation between p27Kip1 expression and cell proliferation in the normal mucosa and tumor samples. There was, however, an inverse correlation between p27Kip1 and Ki67 expression in the lymphoid follicles present in the colonic mucosa. There was no evidence for a consistent increase or decrease in p27Kip1 expression in the mucosal cells during colon carcinogenesis, because the mean values for percentage p27Kip1-positive cells were similar in the normal mucosa, adenomatous polyps, and carcinoma samples. This is in contrast to Ki67 and cyclin D1 expression, which did show significant increases in mean values with tumor development. A subset (35%) of the carcinomas displayed diffuse cytoplasmic staining, in addition to nuclear staining, for p27Kip1, and in these cases the percentage of cells that were positive for p27Kip1 was higher than in cases that had only nuclear staining. There was a significant correlation between p27Kip1 expression and tumor grade; ie., well and moderately differentiated carcinomas had high p27Kip1 expression, whereas poorly differentiated carcinomas had lower expression. The Western blot analysis data on p27Kip1 expression confirmed this correlation. Comparisons of Northern and Western blots did not show a correlation between the level of p27Kip1 mRNA and the corresponding protein, a finding consistent with evidence that the p27Kip1 protein is regulated mainly via a posttranscriptional mechanism. The immunostaining studies revealed a significant correlation between high p27Kip1 protein expression and high cyclin D1 expression in the adenomatous polyps and in the subset of carcinomas that had only nuclear p27Kip1 expression. This may reflect the existence of a homeostatic feedback mechanism that is lost in the high-grade carcinomas that express low levels of p27Kip1.
细胞周期蛋白依赖性激酶抑制剂p27Kip1可抑制细胞周期从G1期向S期的转变,是一种假定的肿瘤抑制因子。然而,我们实验室发现多种人类癌细胞系中该蛋白表达水平相对较高,且这常与细胞周期蛋白D1或细胞周期蛋白E的表达增加相关。因此,在本研究中,我们采用免疫组织化学方法分析了一系列代表结肠癌发生不同阶段的人类组织样本中p27Kip1的表达情况,这些样本包括20份正常结肠黏膜、20份增生性息肉、19份腺瘤性息肉以及40份不同类型的结肠直肠癌样本。同时对细胞周期蛋白D1以及Ki67进行平行免疫染色以评估细胞增殖情况。另外,采用蛋白质印迹分析方法检测了17份人类结肠癌样本及其配对的相邻正常黏膜样本中p27Kip1蛋白的表达水平,其中7对样本采用Northern印迹分析检测p27Kip1 mRNA水平。我们未在正常黏膜和肿瘤样本中发现p27Kip1表达与细胞增殖之间存在正相关或负相关。然而,在结肠黏膜中的淋巴滤泡中,p27Kip1与Ki67的表达呈负相关。在结肠癌发生过程中,未发现黏膜细胞中p27Kip1表达有持续增加或减少的证据,因为正常黏膜、腺瘤性息肉和癌样本中p27Kip1阳性细胞百分比的平均值相似。这与Ki67和细胞周期蛋白D1的表达情况相反,它们的平均值确实随肿瘤进展而显著增加。一部分(35%)的癌除核染色外,p27Kip1还呈现弥漫性胞质染色,在这些病例中,p27Kip1阳性细胞的百分比高于仅存在核染色的病例。p27Kip1表达与肿瘤分级之间存在显著相关性;即高分化和中分化癌具有较高的p27Kip1表达,而低分化癌的表达较低。蛋白质印迹分析关于p27Kip1表达的数据证实了这种相关性。Northern印迹和蛋白质印迹的比较未显示p27Kip1 mRNA水平与相应蛋白之间存在相关性,这一发现与p27Kip1蛋白主要通过转录后机制调控的证据一致。免疫染色研究显示,在腺瘤性息肉以及仅具有核p27Kip1表达的癌亚组中,p27Kip1蛋白高表达与细胞周期蛋白D1高表达之间存在显著相关性。这可能反映了一种稳态反馈机制的存在,而在p27Kip1表达水平低的高级别癌中这种机制丧失。